| Primary |
| Hypertension |
40.0% |
| Aortic Valve Stenosis |
5.7% |
| Atrial Fibrillation |
5.7% |
| Drug Use For Unknown Indication |
5.7% |
| Parkinson's Disease |
5.7% |
| Suicide Attempt |
5.7% |
| Abscess |
2.9% |
| Acute Coronary Syndrome |
2.9% |
| Angina Pectoris |
2.9% |
| Blood Cholesterol Increased |
2.9% |
| Essential Hypertension |
2.9% |
| Hypercholesterolaemia |
2.9% |
| Ischaemia |
2.9% |
| Lung Abscess |
2.9% |
| Oedema |
2.9% |
| Oesophagitis |
2.9% |
| Tachycardia |
2.9% |
|
| Nausea |
13.3% |
| Drug Interaction |
6.7% |
| General Physical Health Deterioration |
6.7% |
| Intentional Overdose |
6.7% |
| Left Ventricular Dysfunction |
6.7% |
| Paraesthesia |
6.7% |
| Pharmaceutical Product Complaint |
6.7% |
| Rash Macular |
6.7% |
| Renal Failure |
6.7% |
| Skin Exfoliation |
6.7% |
| Suicide Attempt |
6.7% |
| Ventricular Extrasystoles |
6.7% |
| White Blood Cell Count Increased |
6.7% |
| Wound |
6.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.8% |
| Product Used For Unknown Indication |
15.9% |
| Hypertension |
13.0% |
| Lung Abscess |
8.7% |
| Arteriogram Coronary |
5.8% |
| Bacterial Infection |
4.3% |
| Hepatitis C |
4.3% |
| Arrhythmia |
2.9% |
| Atrial Fibrillation |
2.9% |
| Cardiac Failure Congestive |
2.9% |
| Constipation |
2.9% |
| Diabetes Mellitus |
2.9% |
| Myocardial Infarction |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Acute Coronary Syndrome |
1.4% |
| Anaemia |
1.4% |
| Angina Pectoris |
1.4% |
| Benign Prostatic Hyperplasia |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Breast Cancer |
1.4% |
|
| Renal Disorder |
18.2% |
| Skin Exfoliation |
9.1% |
| Arterial Therapeutic Procedure |
4.5% |
| Atrial Fibrillation |
4.5% |
| Blood Creatinine Increased |
4.5% |
| Cardiac Failure Chronic |
4.5% |
| Injection Site Reaction |
4.5% |
| Intentional Overdose |
4.5% |
| Nausea |
4.5% |
| Nodal Rhythm |
4.5% |
| Oral Intake Reduced |
4.5% |
| Pneumonia |
4.5% |
| Pyrexia |
4.5% |
| Renal Failure |
4.5% |
| Renal Failure Acute |
4.5% |
| Torsade De Pointes |
4.5% |
| Toxic Skin Eruption |
4.5% |
| Weight Decreased |
4.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.0% |
| Product Used For Unknown Indication |
20.2% |
| Hypertension |
12.6% |
| Angina Pectoris |
4.5% |
| Prophylaxis |
3.6% |
| Hepatitis C |
3.4% |
| Rheumatoid Arthritis |
2.7% |
| Atrial Fibrillation |
2.1% |
| Plasma Cell Myeloma |
2.1% |
| Diabetes Mellitus |
2.0% |
| Depression |
1.8% |
| Myocardial Ischaemia |
1.7% |
| Pain |
1.7% |
| Asthma |
1.5% |
| Osteoporosis |
1.5% |
| Breast Cancer |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Anaemia |
1.3% |
| Anxiety |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
|
| Drug Reaction With Eosinophilia And Systemic Symptoms |
11.9% |
| Atrial Fibrillation |
6.0% |
| Malaise |
6.0% |
| Psychotic Disorder |
6.0% |
| Syncope |
6.0% |
| Vomiting |
6.0% |
| Breast Cancer |
4.5% |
| Myalgia |
4.5% |
| Myocardial Infarction |
4.5% |
| Nausea |
4.5% |
| Pneumonia |
4.5% |
| Proctalgia |
4.5% |
| Proteinuria |
4.5% |
| Pyrexia |
4.5% |
| Rectal Haemorrhage |
4.5% |
| Upper Gastrointestinal Haemorrhage |
4.5% |
| Urticaria |
4.5% |
| Angina Pectoris |
3.0% |
| Cardiac Failure |
3.0% |
| Cerebrovascular Accident |
3.0% |
|
